Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease
- 1 July 2004
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 78 (1) , 216-221
- https://doi.org/10.1016/j.athoracsur.2004.02.009
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Serum carcinoembryonic antigen level in surgically resected clinical stage i patients with non-small cell lung cancerThe Annals of Thoracic Surgery, 2002
- The Usefulness of Carcinoembryonic Antigen Testing in the Overall Management of Patients With Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1998
- Pretreatment Evaluation of Non–Small-cell Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancerThe Annals of Thoracic Surgery, 1994
- Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: Immunocytochemical localization and serum levelsBritish Journal of Cancer, 1981
- Carcinoembryonic antigen: its role as a marker in the management of cancer. Summary of an NIH consensus statement.BMJ, 1981
- Measurement of carcinoembryonic antigen in patients with bronchogenic carcinomaCancer, 1978
- Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinomaCancer, 1978